24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
@Finance
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Fosun Pharma
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
18:20
The World Cup warning: Riots don’t start in the streets. They start online
18:07
“There’s a price where you have to say yes”: CyberArk founder on the $25 billion Palo Alto deal
14:18
"If there is no significant change, we will see a 25%-30% reduction in high-tech's workforce"
13:32
“There is no better solution for Zim than the one we created”
More stories
Buzz
Most popular
Daily
Weekly
1
"If an engineer in Ireland costs 20% less, it is clearly part of the consideration when deciding where to expand"
2
Iron Dome and Iron Beam maker Rafael unveils new weapon against the drone threat
3
"If there is no significant change, we will see a 25%-30% reduction in high-tech's workforce"
4
Echo: “Employees have become very good at identifying performative culture”
5
Unicorn Artlist to cut 200 jobs, 40% of workforce, despite surpassing $300 million ARR
More news
Fosun Pharma
8 stories about Fosun Pharma
Israel's Mitrassist Medical raises $50 million for medical valve development
02.12.20
|
Meir Orbach
China's Fosun Pharma, insurance company Ping-An and four large Chinese funds all took part in the round
Double-chin reducing Israeli startup closes $74 million China licensing deal
22.09.20
|
Meir Orbach
The agreement provides JuveStar with exclusive rights to develop and commercialize Raziel Therapeutics’ proprietary RZL-012 compound
Fosun Whetted Our Appetite, Says Alma Lasers CEO
04.07.19
|
Golan Hazani
Fosun Pharma CEO Yifang Wu and Alma Lasers CEO Lior Dayan gave Calcalist their first joint interview since the Chinese conglomerate acquired the Israeli medical laser company in 2013
Fosun Pharma Subsidiary Sisram Medical Leases 11,000-Square-Meter Building in Caesarea
10.12.18
|
Dotan Levy
The ten-year lease is estimated at $1.7 million (NIS 6.3 million) per year. China’s Fosun Pharma bought Sisram in 2014 for $240 million, renaming it from Alma Lasers
Fosun Pharma Acquires Israeli Distributer Via Israeli Subsidiary Sisram
28.11.18
|
Golan Hazani
Sisram Medical, formerly Alma Lasers, is buying Nova Medical, one of the largest distributors of medical aesthetic devices in Israel
Fosun Leads $30 Million Round for Heart Valve Company MitrAssist
08.11.17
|
Lilach Baumer
The Israel-based company develops a valve implant that can be installed through thigh catheterization instead of invasive heart surgery
Sisram Stock Price Down on Market Debut
19.09.17
|
Amarelle Wenkert
The Fosun Pharma subsidiary debuted on the Hong Kong Stock Exchange Tuesday
Sisram Medical Seeks to Raise Up To $176 Million in Hong Kong IPO
10.09.17
|
Amarelle Wenkert
On September 5, the Fosun Pharma subsidiary submitted a prospectus to the Hong Kong Stock Exchange